HY-10505-10mg
|
MedChemexpress LLC
|
Orteronel [CAS 566939-85-3]
|
|
Cancer-programmed cell death
|
|
HY-10505-25mg
|
MedChemexpress LLC
|
Orteronel [CAS 566939-85-3]
|
|
Cancer-programmed cell death
|
|
HY-10505-5mg
|
MedChemexpress LLC
|
Orteronel [CAS 566939-85-3]
|
|
Cancer-programmed cell death
|
|
HY-10505-50mg
|
MedChemexpress LLC
|
Orteronel [CAS 566939-85-3]
|
|
Cancer-programmed cell death
|
|
HY-10505-1mL
|
MedChemexpress LLC
|
Orteronel [CAS 566939-85-3] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-P99391-1mg
|
MedChemexpress LLC
|
Telisotuzumab [CAS 1781223-80-0]
|
|
Cancer-programmed cell death
|
|
HY-P99391-10mg
|
MedChemexpress LLC
|
Telisotuzumab [CAS 1781223-80-0]
|
|
Cancer-programmed cell death
|
|
HY-P99391-5mg
|
MedChemexpress LLC
|
Telisotuzumab [CAS 1781223-80-0]
|
|
Cancer-programmed cell death
|
|
HY-W008469-100mg
|
MedChemexpress LLC
|
2-Fluoroadenine [CAS 700-49-2]
|
|
Cancer-programmed cell death
|
|
HY-W008469-250mg
|
MedChemexpress LLC
|
2-Fluoroadenine [CAS 700-49-2]
|
|
Cancer-programmed cell death
|
|
HY-19987-10mg
|
MedChemexpress LLC
|
BML-284 [CAS 853220-52-7]
|
|
Cancer-programmed cell death
|
|
HY-19987-100mg
|
MedChemexpress LLC
|
BML-284 [CAS 853220-52-7]
|
|
Cancer-programmed cell death
|
|
HY-19987-200mg
|
MedChemexpress LLC
|
BML-284 [CAS 853220-52-7]
|
|
Cancer-programmed cell death
|
|
HY-19987-5mg
|
MedChemexpress LLC
|
BML-284 [CAS 853220-52-7]
|
|
Cancer-programmed cell death
|
|
HY-19987-50mg
|
MedChemexpress LLC
|
BML-284 [CAS 853220-52-7]
|
|
Cancer-programmed cell death
|
|
HY-19987-1mL
|
MedChemexpress LLC
|
BML-284 [CAS 853220-52-7] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-W013272-10mg
|
MedChemexpress LLC
|
Hydroxyflutamide [CAS 52806-53-8]
|
|
Cancer-programmed cell death
|
|
HY-W013272-100mg
|
MedChemexpress LLC
|
Hydroxyflutamide [CAS 52806-53-8]
|
|
Cancer-programmed cell death
|
|
HY-W013272-25mg
|
MedChemexpress LLC
|
Hydroxyflutamide [CAS 52806-53-8]
|
|
Cancer-programmed cell death
|
|
HY-W013272-5mg
|
MedChemexpress LLC
|
Hydroxyflutamide [CAS 52806-53-8]
|
|
Cancer-programmed cell death
|
|
HY-W013272-50mg
|
MedChemexpress LLC
|
Hydroxyflutamide [CAS 52806-53-8]
|
|
Cancer-programmed cell death
|
|
HY-N0170-1g
|
MedChemexpress LLC
|
Indole-3-carbinol [CAS 700-06-1]
|
|
Cancer-programmed cell death
|
|
HY-N0170-200mg
|
MedChemexpress LLC
|
Indole-3-carbinol [CAS 700-06-1]
|
|
Cancer-programmed cell death
|
|
HY-N0170-1mL
|
MedChemexpress LLC
|
Indole-3-carbinol [CAS 700-06-1] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-R03740-20nmol
|
MedChemexpress LLC
|
mMu -miR-700-3p mimic
|
|
Cancer-programmed cell death
|
|